NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Health Information Services · USD

HeartBeam, Inc. (BEAT) Stock Analysis

HeartBeam, Inc. (BEAT) is a Health Information Services stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

BEAT

$0.41

−$0.00 (−0.93%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare BEAT with… →

BEAT Key Statistics

As of Oct 21, 2026
Trading
Open
$0.42
Previous Close
$0.41
Day's Range
0.40–0.42
52-Week Range
0.36–4.00
Volume
368.69K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
−0.77
Valuation
Market Cap
$23.15M
P/E Ratio
unprofitable
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.50
Financials (FY)
Revenue (FY)
$0.00
Net Income (FY)
−$21.02M
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
56.35M
1-Year Return
−75.18%
Dividend and dates
Earnings Date
November 12, 2026estimated
Avg Volume
7.23M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, BEAT closed at $0.41, −75.18% over 1 year.

HeartBeam, Inc. (BEAT) has a market capitalization of $23.15M.

In fiscal 2025, BEAT reported revenue of $0.00.

BEAT Stock Return by Calendar Year

HeartBeam, Inc. (BEAT) return since Nov 2021: what $10,000 became

1 year
$10,000 $2,482
−75.18%
5 years
$10,000 $868
−91.32%

If you had invested $10,000 in HeartBeam, Inc. (BEAT) at the close on November 11, 2021, the earliest close on record here, it would have been worth $868 at the close on October 21, 2026: −91.32% in total, −38.67% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−83.04%
2025+4.35%
2024−2.13%
2023−51.84%
2022+58.44%
2021 (partial year)−34.33%

As of October 21, 2026.

BEAT Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$0.00−$21.02M—
2024$0.00−$19.45M—
2023$0.00−$14.64M—
2022$0.00−$12.96M—
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$0.00—−$21.14M−$21.02M—
2024$0.00—−$19.89M−$19.45M—
2023$0.00—−$15.31M−$14.64M—
2022$0.00—−$13.03M−$12.96M—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

Recent News

All 13 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values HeartBeam, Inc. (BEAT) at $23.15M. It is classified in the Health Information Services industry, within the Healthcare sector. The company reports 16 employees.

The 52-week range on file runs from $0.36 to $4.00. BEAT last closed at $0.41 on October 21, 2026. That is $0.00 (−0.93%) against the previous close. The latest close sits 14.65% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $0.00. The same year closed with a net loss of $21.02M. Trailing earnings per share are −0.5.

Across the 4 fiscal years on file, revenue moves from $0.00 in 2022 to $0.00 in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative.

The trailing one-year total return is −75.18%. Across 5 years the annualized return works out at −38.67%. Beta against the wider market is reported at −0.77. Daily returns over the trailing 4 years annualize to a volatility of 111.94%.

Growth & Income

No dividend is on file for BEAT.

The strongest complete calendar year on file is 2022 at +58.44%; the weakest is 2023 at −51.84%. Of the 4 complete calendar years on file, 2 finished higher. 2026 is still running; the total return is −83.04% year to date.

Peer Comparison

HeartBeam, Inc. (BEAT) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
HeartBeam, Inc. BEAT $23.15M —
Veeva Systems Inc. VEEV $51.90B 52.6
BrightSpring Health Services, Inc. BTSG $12.40B 55.4
Tempus AI, Inc. TEM $12.23B —

The Health Information Services industry average P/E ratio is 46.5x. HeartBeam, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Health Information Services Stocks

VEEV

Veeva Systems Inc.

$51.90B

 BTSG

BrightSpring Health Services, Inc.

$12.40B

 TEM

Tempus AI, Inc.

$12.23B

 HNGE

Hinge Health, Inc.

$9.04B

 HQY

HealthEquity, Inc.

$8.10B

 DOCS

Doximity, Inc.

$5.99B
View all Health Information Services stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About HeartBeam, Inc.

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.

Visit website →